
European Journal of Medicinal Chemistry p. 171 - 180 (1998)
Update date:2022-08-04
Topics:
Amblard, Muriel
Rodriguez, Marc
Lignon, Marie-Francoise
Galas, Marie-Christine
Bernad, Nicole
Aumelas, Andre
Martinez, Jean
We reported earlier on the synthesis and biological activity at the CCK-B receptor of cyclized derivatives of CCK. These peptides, in which the positions 28 and 31 were replaced by lysine residues, were bridged by a succinyl moiety. To determine the importance of the nature and size of the cyclic structure, cyclic analogues were synthesized in which: (i) the lysine residues were replaced by ornithine and diaminobutyric acid and (ii) the succinic moiety was replaced by a malonic, adipic and glutaric moiety. They were tested For their ability to inhibit the specific binding of 125I-BH-CCK-8 to CCK receptors in rat pancreatic acini and guinea pig brain membranes. They were also evaluated for their ability to stimulate amylase secretion from rat pancreatic acini. The potency and selectivity of these analogues were compared with those obtained with CCK-4 and compound JIMV320, a potent and selective CCK-B receptor ligand synthesized earlier in our laboratory.
View MoreContact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
Contact:+86-571-86217390
Address:No.567 Dengcai Street,Sandun,Westlake District,Hangzhou310030,Zhejiang,China.
Contact:86-371-63655023
Address:No.85,jinshui road,zhengzhou,China
PharmaResources(Kaiyuan)CO,.Ltd
Contact:+86-21-50720028
Address:No.3, Beihuan Road, Economic Development District, Kaiyuan City, Tieling City, Liaoning Province, China 112300
GUANGZHOU MEDCAN PHARMATECH LTD
website:http://www.gzmedcan.com
Contact:+86-20-82519649
Address:Building J,Room 101,1 JiangtashanRd,Guang Zhou Science City,Guang Zhou ,China
Doi:10.1021/ja972897e
(1998)Doi:10.1016/j.ejmech.2016.05.022
(2016)Doi:10.1021/jo00207a003
(1985)Doi:10.1021/jo00207a002
(1985)Doi:10.1055/s-2008-1067214
(2008)Doi:10.1021/jo01064a049
(1961)